XSTRAHL

Xstrahl, whose corporate vision is “to help eradicate cancer”, is a leading designer and manufacturer of medical devices in the treatment of cancers and dermatological disorders, as well as a pioneer in the development of advanced X–ray systems for pre-clinical radiation biology research.

For over 15 years, Xstrahl medical systems have reliably supported healthcare professionals and patients in over 500 clinics around the world. 

​

The company is headquartered in Britain and has facilities in the US. Exporting to over 25 countries, its customers are mainly hospitals and universities.

KEY DEAL CHARACTERISTICS

​

• Vendor Instigated MBI

• Complex international group structure

• Structured deal comprising cash and loan notes

“THE WHOLE PROCESS, TOOK TWELVE MONTHS FROM FIRST CONTACT, THE WRITING OF THE INVESTMENT MEMORANDUM, CIRCULATION TO INTERESTED PARTIES AND OBTAINING A REALISTIC PRICE FOR THE BUSINESS FOLLOWING EXTENSIVE DUE DILIGENCE BY THE ACQUIRER’S PROFESSIONAL ADVISORS WAS HANDLED WITH PROFESSIONALISM AND UNSTINTING RESOURCES BY THE LOCKDUTTON TEAM”.

Martin Robinson

Executive Chairman, Xstrahl